Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 8/20 | 0.64 |
| ▸ | CA2 | P00918 | 8/20 | 0.64 |
| ▸ | CA9 | Q16790 | 7/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 2/20 | 0.55 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.53 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9155561 | 0.81 | MEN1 (0.59) | CA12CA2CA9MEN1KMT2A | |
| SCHEMBL5351043 | 0.81 | MEN1 (0.84) | CA12CA2CA9MEN1KMT2A | |
| SCHEMBL9155564 | 0.81 | MEN1 (0.59) | CA12CA2CA9MEN1KMT2A | |
| SCHEMBL5353261 | 0.81 | MEN1 (0.84) | CA12CA2CA9MEN1KMT2A | |
| SCHEMBL14467517 | 0.76 | CA2 (0.59) | CA12CA2CA9MEN1KMT2A | |
| SCHEMBL28217410 | 0.75 | CA2 (0.65) | CA12CA2CA9MEN1KMT2A | |
| SCHEMBL27918619 | 0.75 | MEN1 (0.73) | MEN1KMT2ACYP1B1CYP1A1NPC1 | |
| SCHEMBL27918752 | 0.75 | MEN1 (0.73) | MEN1KMT2ACYP1B1CYP1A1NPC1 | |
| SCHEMBL10766960 | 0.75 | CA2 (0.57) | CA12CA2CA9MEN1KMT2A | |
| SCHEMBL2777355 | 0.74 | MEN1 (0.72) | MEN1KMT2ACYP1B1CYP1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371724-A | Rubber supercritical foaming material for sole and preparation process thereof | 李宁（中国）体育用品有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-119296730-A | Intelligent nutrition evaluation and nutrition exercise intervention system based on nutrition and exercise principle | 益美佳(沈阳)智能科技有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-118542947-A | Micro-nano robot and application thereof in preparation of medicines for treating thrombotic diseases | 厦门大学 | 2024-08-27 | — | — | CN | claimed |
| US-20260148321-A1 | AUTOMATED VENDOR INVOICE DISPUTE SYSTEM | KENVUE BRANDS LLC (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260111824-A1 | SYSTEM AND METHOD FOR AUTOMATED IDENTIFICATION OF CHURNED CLIENTS AND PREDICTIVE ASSESSMENT OF ATTRITION LIKELIHOOD | ORACLE INT CORP (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260008747-A1 | SELECTIVE MONOARYLATIONS OF HYDRAZINES | RUHR-UNIVERSITAET BOCHUM (DE) | 2026-01-08 | — | — | US | disclosed |
| US-12502072-B1 | Systems and methods for automated hypertensive retinopathy (HTNR) detection | iHealthScreen Inc. (US) | 2025-12-23 | — | — | US | disclosed |
| US-12451182-B2 | Nonvolatile memory device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-21 | — | — | US | disclosed |
| US-20250316316-A1 | SEMICONDUCTOR DEVICE | SK Hynix Inc. (KR) | 2025-10-09 | — | — | US | disclosed |
| EP-4591938-A2 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | Sapreme Technologies B.V. (NL) | 2025-07-30 | — | — | EP | disclosed |
| US-20250223339-A1 | SARS-COV2 ANTIBODIES AND USES THEREOF | INVIVYD INC (US) | 2025-07-10 | — | — | US | disclosed |
| WO-2022063646-A1 | PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2022-03-31 | — | — | WO | disclosed |
| WO-2022055351-A1 | CONJUGATE OF SAPONIN, OLIGONUCLEOTIDE AND GALNAC | SAPREME TECHNOLOGIES B.V. (NL) | 2022-03-17 | — | — | WO | disclosed |
| CN-112779623-B | Composition for cutting-resistant fiber, application and preparation method | 安丹达工业技术(上海)有限公司 | 2022-03-15 | — | — | CN | disclosed |
| US-20160369237-A1 | METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY | ADVANCED CELL TECH INC (US) | 2016-12-22 | — | — | US | disclosed |
| US-20100184033-A1 | METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY | Lineage Cell Therapeutics, Inc. | 2010-07-22 | — | — | US | disclosed |
| US-20080226601-A1 | Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods | UNIVERSITY OF ROCHESTER (US) | 2008-09-18 | — | — | US | disclosed |
| EP-1903873-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | THE UNIVERSITY OF ROCHESTER (US) | 2008-04-02 | — | — | EP | disclosed |
| US-20080070303-A1 | Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement | ADVANCED CELL TECHNOLOGY | 2008-03-20 | — | — | US | disclosed |
| WO-2006135602-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | UNIVERSITY OF ROCHESTER (US) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008747-A1 | SELECTIVE MONOARYLATIONS OF HYDRAZINES | AP3S1, HRH2, AP2S1 | CA12 4671/4885CA2 4401/4885CA9 4653/4885 |
| US-20260111824-A1 | SYSTEM AND METHOD FOR AUTOMATED IDENTIFICATION OF CHURNED CLIENTS AND PREDICTIVE ASSESSMENT OF ATTRITION LIKELIHOOD | ALK, CD40, CCR6 | CA12 2548/4885CA2 3292/4885CA9 1658/4885 |
| US-20260148321-A1 | AUTOMATED VENDOR INVOICE DISPUTE SYSTEM | EXOSC10, INTS6, IPO11 | CA12 4025/4885CA2 4434/4885CA9 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.